601607 On Other Exchanges
601607 is not on other exchanges.

shanghai pharmaceuticals-a (601607) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SHANGHAI PHARMACEUTICALS-A (601607)

Related News

No related news articles were found.

shanghai pharmaceuticals-a (601607) Related Businessweek News

No Related Businessweek News Found

shanghai pharmaceuticals-a (601607) Details

Shanghai Pharmaceuticals Holding Co., Ltd., together with its subsidiaries, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People’s Republic of China. It operates through Production, Distribution, Retail, and Others segments. The company offers a range of products, including chemical and bio-pharms, modern Chinese medicine, healthcare products, medical devices, etc. in various therapeutic areas, such as cardiovascular, systemic anti-infections, digestive system and immune-metabolism, neuropsychiatric, and antineoplastic, as well as anti-tumor and immunomodulatory, musculo-skeletal, respiratory, genito-urinary and sex hormone, blood and blood-forming organ, neurological, and other therapeutic areas. It provides its products in various dosage forms that include tablets, capsules, powder, mini-volume injections, eye-drops, inhalants, coagulants, etc. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it operates a network of retail pharmacy stores, as well as engages in consulting service, assets management, investment holding operations, etc. Further, the company manufactures and trades medicines and medical equipment; and rents properties, as well as wholesales chemicals and active pharmaceutical ingredients. As of December 31, 2015, it had 1,769 chain retail pharmacies under its brand family, including 1,167 directly operated pharmacies. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

39,844 Employees
Last Reported Date: 08/25/16
Founded in 1994

shanghai pharmaceuticals-a (601607) Top Compensated Officers

President, Executive Director and Convener of...
Total Annual Compensation: CNY2.0M
Vice President
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

shanghai pharmaceuticals-a (601607) Key Developments

Shanghai Pharmaceuticals Holding Co., Ltd. Appoints Zhou Jun as Chairman of the Board and Member of Nomination Committee

Shanghai Pharmaceuticals Holding Co., Ltd. announced that Mr. Zhou Jun, a newly elected non-executive director of the company, has been appointed as the chairman of the Board of the company and a member of the nomination committee of the Board with effect from 20 October 2016 until the expiry of the term of the sixth session of the Board. He has over 20 years of professional experience in securities, merger and acquisition, finance, real estate, project planning and corporate management. He is currently the chairman of the Board and a non-executive director of the company and does not hold any directorship in the subsidiaries of the company. He has been a president and an executive director of Shanghai Industrial Investment (Holdings) Co., Ltd. since September 2016 and May 2012, respectively. He has also been the vice chairman and the chief executive officer since August 2016.

Shanghai Pharmaceuticals Holding Co., Ltd. Approves Amendments to the Articles of Association

The first extraordinary general meeting of 2016 of Shanghai Pharmaceuticals Holding Co., Ltd. was held on 20 October 2016. The meeting has approved the proposal regarding the amendments to the Articles of Association of the company.

Shanghai Pharmaceuticals Holding Co., Ltd., Board Meeting, Oct 20, 2016

Shanghai Pharmaceuticals Holding Co., Ltd., Board Meeting, Oct 20, 2016. Agenda: To discuss and approve the proposal of electing chair of 6th directorate; to discuss and approve the proposal of appointing authorization representative; and to discuss and approve the proposal of changing authorization representative of ESS System of Hong Kong Exchanges and Clearing Limited.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

601607 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 601607.
View Industry Companies

Industry Analysis


Industry Average

Valuation 601607 Industry Range
Price/Earnings 17.3x
Price/Sales 0.5x
Price/Book 1.7x
Price/Cash Flow 12.3x
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SHANGHAI PHARMACEUTICALS-A, please visit www.pharm-sh.com.cn. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.